Topics:

Diabetes Type 2

Type 2 Diabetes and Medication Adherence: Where is the Disconnect?

Incretin drugs, which offer ease of use, very little hypoglycemia, and no weight gain (or even weight loss) seem to be an ideal therapy. But 80% to 90% of patients don’t stay on them. Why not?
 

Diabetes Type 2

Mycosis fungoides; circumscribed erythematous lesions in a toddler; large abdominal ecchymotic mass . . . some of the challenges for you in this quiz.

Contrave, a combination of naltrexone and buproprion, has been approved for long-term weight loss management in overweight and obese adults.

Some researchers now suspect that type 2 diabetes may itself be an independent risk factor for osteoarthritis and have proposed a "diabetes-induced phenotype."

Inpatient hyperglycemia found on admission blood tests can be explained by medications, stress reaction, or, "Other." When is "other" a red flag for diabetes? A new online tool from Scotland may help answer that.

Not all patients who meet indications for statin therapy are at equal risk for the development of diabetes. What would you tell this 58-year-old man who just learned he's a candidate for a high-potency formulation?

Use these 5 brief summaries of recent developments in the study of diabetes and trends in diabetes care to stay current and optimize care for your patients.

Pages

Subscribe to Diabetes Type 2 on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.